These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15147513)

  • 21. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Fundam Clin Pharmacol; 2007 Jun; 21(3):297-306. PubMed ID: 17521299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebselen protects against behavioral and biochemical toxicities induced by 3-nitropropionic acid in rats: correlations between motor coordination, reactive species levels, and succinate dehydrogenase activity.
    Wilhelm EA; Bortolatto CF; Jesse CR; Luchese C
    Biol Trace Elem Res; 2014 Dec; 162(1-3):200-10. PubMed ID: 25277606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C; Condé F; Brouillet E; Mittoux V; Beal MF; Bloch G; Hantraye P
    Neurobiol Dis; 1999 Aug; 6(4):259-68. PubMed ID: 10448053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.
    Lee WT; Chang C
    Prog Neurobiol; 2004 Feb; 72(2):87-110. PubMed ID: 15063527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
    Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
    J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
    J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
    Wang X; Sarkar A; Cicchetti F; Yu M; Zhu A; Jokivarsi K; Saint-Pierre M; Brownell AL
    J Neurol Sci; 2005 Apr; 231(1-2):57-66. PubMed ID: 15792822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRS glucose mapping and PET joining forces: re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia.
    Alf MF; Duarte JM; Lei H; Krämer SD; Mlynarik V; Schibli R; Gruetter R
    J Neurochem; 2014 May; 129(4):672-82. PubMed ID: 24471521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Methods Find Exp Clin Pharmacol; 2007; 29(1):19-25. PubMed ID: 17344940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Methamphetamine Effects on Brain Structure and Function in Rats.
    Thanos PK; Kim R; Delis F; Ananth M; Chachati G; Rocco MJ; Masad I; Muniz JA; Grant SC; Gold MS; Cadet JL; Volkow ND
    PLoS One; 2016; 11(6):e0155457. PubMed ID: 27275601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of MK-801 on L-2-chloropropionic acid-induced neurotoxicity.
    Williams RE; Lock EA; Bachelard HS
    J Neurochem; 2001 Feb; 76(4):1057-65. PubMed ID: 11181825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain.
    Sugino T; Nozaki K; Takagi Y; Hattori I; Hashimoto N; Yodoi J
    Neurosci Lett; 1999 Nov; 275(2):145-8. PubMed ID: 10568520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration.
    Newcomb JD; Brown WD; Rodriguez AI; Garbuzova-Davis S; Saporta S; Sanberg PR; Willing AE
    Neurotox Res; 2005 Nov; 8(3-4):259-66. PubMed ID: 16371320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-[13C] NMR spectroscopy.
    Henry PG; Lebon V; Vaufrey F; Brouillet E; Hantraye P; Bloch G
    J Neurochem; 2002 Aug; 82(4):857-66. PubMed ID: 12358791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.
    Kumar P; Kalonia H; Kumar A
    Eur J Pharmacol; 2012 Jan; 674(2-3):265-74. PubMed ID: 22154757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms.
    Jang M; Lee MJ; Cho IH
    Brain Behav Immun; 2014 May; 38():151-65. PubMed ID: 24576481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.